# K141073: Liquichek Tumor Marker Control

- Pathway: 510(k) (Traditional)
- Applicant: Bio-Rad Laboratories
- Decided: Jun 23, 2014 after 59 days
- Product code: JJY (Multi-Analyte Controls, All Kinds (Assayed))
- Device class: 1
- Regulation: 21 CFR 862.1660
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K940433 (1994). 5 ancestors in all.
No later device cites it as a predicate yet.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K071675: Liquichek Tumor Marker Control, Bio-Rad Laboratories (2007) Summary page 1.

## Indications for use
Liquichek Tumor Marker Control is intended for use as an assayed quality control serum to monitor the precision of laboratory testing procedures for the analytes listed in this package insert. Analytes: Alpha Fetoprotein (AF?) Beta-2-Microglobulin (B2-M) CA 15-3 CA 19-9 CA 125 Carcinoembryoriic Antigen (CEA) Ferritin Human Chorionic Gonadotropin (hCG) Pro lact in Prostate Specific Antigen, Total (Total PSA) Prostate Specific Antigen, Free (Free PSA)

Source page: https://510kreport.com/device/K141073
Methodology: https://510kreport.com/methodology